Surge in Federal Approvals Buoys Drug Makers

Something odd is going on in the pharmaceutical world: Though the industry is coping with a sluggish economy and bracing for federal cuts in medical research funding, the mood among the 8,000 executives at the industry’s premier investors conference is decidedly upbeat.
The Boston Globe